First Real Estate Investment Trust Of New Jersey FREVS
We take great care to ensure that the data presented and summarized in this overview for FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in FREVS
Top Purchases
Top Sells
About FREVS
First Real Estate Investment Trust of New Jersey is a publicly traded (over-the-counter ? symbol FREVS.) REIT organized in 1961. Its portfolio of residential and commercial properties are located in New Jersey, New York and Maryland, with the largest concentration in northern New Jersey.
Insider Transactions at FREVS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2025
|
David F Mcbride Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+1.71%
|
-
|
|
Feb 20
2025
|
Justin Meng Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+1.69%
|
-
|
|
Feb 20
2025
|
John A Aiello Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+4.13%
|
-
|
|
Feb 20
2025
|
Ronald J Artinian Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+0.24%
|
-
|
|
Feb 20
2025
|
Richard Aslanian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+2.15%
|
-
|
|
Feb 20
2025
|
David Hekemian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+0.55%
|
-
|
|
Feb 20
2025
|
Robert S Hekemian Jr Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+0.54%
|
-
|
|
Oct 18
2024
|
Richard Aslanian Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+6.69%
|
$30,400
$8.0 P/Share
|
|
Sep 27
2024
|
David F Mcbride Director |
SELL
Open market or private sale
|
Direct |
3,000
-4.27%
|
$51,000
$17.04 P/Share
|
|
Sep 17
2024
|
David F Mcbride Director |
SELL
Open market or private sale
|
Direct |
6,000
-4.01%
|
$96,000
$16.99 P/Share
|
|
Sep 10
2024
|
Ronald J Artinian Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.2%
|
$7,000
$7.5 P/Share
|
|
Mar 22
2024
|
Justin Meng Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+1.77%
|
-
|
|
Mar 22
2024
|
Ronald J Artinian Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+0.25%
|
-
|
|
Mar 22
2024
|
Richard Aslanian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+2.44%
|
-
|
|
Mar 22
2024
|
David Hekemian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+0.57%
|
-
|
|
Mar 22
2024
|
Robert S Hekemian Jr Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+0.56%
|
-
|
|
Mar 22
2024
|
David F Mcbride Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+1.59%
|
-
|
|
Mar 22
2024
|
John A Aiello Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+4.43%
|
-
|
|
May 03
2023
|
David Hekemian Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+1.75%
|
$30,400
$8.0 P/Share
|
|
Apr 06
2023
|
Ronald J Artinian Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.2%
|
$7,000
$7.5 P/Share
|
Last 12 Months Summary
Buy / Acquisition
21.8K
Shares
From
8
Insiders
| Grant, award, or other acquisition | 18K shares |
|---|---|
| Exercise of conversion of derivative security | 3.8K shares |
Sell / Disposition
9K
Shares
From
1
Insiders
| Open market or private sale | 9K shares |
|---|